drugset / Trial / NCT00994825

Levosimendan in High Risk Patients Undergoing Cardiac Surgery

NCT00994825

Phase 4 Completed 1000 enrolled Vita-Salute San Raffaele University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Low cardiac output syndrome (LCOs) is a serious complication in critically ill patients or those undergoing major surgery, resulting in multiple organ damage with significant in-hospital and long-term morbidity and mortality, as well as prolonged hospital stay. In this setting the mortality rate is distressingly high despite improvements in intensive care treatment, but survivors have an acceptable quality of life.

Timeline

Start
2009-11
Primary completion
2016-05
Completion
2016-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Levosimendan Other / unclassified 0.05 ug/kg
Subject Levosimendan Other / unclassified 0.2 ug/kg

Indications

No indication recorded.